Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - SkyePharma plc (NasdaqNM:SKYE)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs | Insider
Location
105 Picadilly
London W1V 9FN, UK
Phone: (212) 753-5780
Fax: (212) 753-9053
Email: insiteco@ix.netcom.com
Employees (last reported count): 375
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 24%
·Institutional: 1% (1% of float)
(18 institutions)
·Net Inst. Buying: 2,000  shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
SkyePharma plc is a public limited company that develops methods for delivering drugs in the human body based on five technology platforms in the following areas: oral, injectable, inhalation, topical and nano-particulate. A significant part of the Company's business is developing applications of its Geomatrix technologies. Geomatrix is a range of technologies by which drugs taken orally in tablet form are formulated so as to control the amount, timing and location of the release of the drug in the body.
More from Market Guide: Expanded Business Description

Financial Summary
SkyePharma plc develops methods for delivering drugs in the human body. The Company, through its Geomatrix technologies, focuses on the amount, timing and location of the release of the drug in the body. For the fiscal year ended 12/00, revenues rose 37% to L24.3 million. Net loss under U.S. GAAP adjustment rose 3% to L29.2 million. Results reflect higher contract R&D and manufacturing revenues, offset by higher R and D expenses, and goodwill amortization.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Ian Gowrie-Smith, 52
Exec. Chairman
$475K
Michael Ashton, 54
CEO, Director
449K
Donald Nicholson, 42
Director and Fin. Director
216K
Suzanne McLean, 46
Sec. and International Legal Counsel
39K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:SKYEAs of 31-Aug-2001
Price and Volume
52-Week Low
on 5-Dec-2000
$8.50 
Recent Price$11.56 
52-Week High
on 2-Mar-2001
$15.625
Beta0.02 
Daily Volume (3-month avg)10.7K
Daily Volume (10-day avg)6,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-5.6%
52-Week Change
relative to S&P500
+26.6%
Share-Related Items
Market Capitalization$598.0M
Shares Outstanding51.7M
Float39.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.94 
Earnings (ttm)-$0.57 
Earnings (mrq)-$0.23 
Sales (ttm)$0.69 
Cash (mrq)$1.21 
Valuation Ratios
Price/Book (mrq)5.96 
Price/EarningsN/A 
Price/Sales (ttm)16.63 
Income Statements
Sales (ttm)$35.3M
EBITDA (ttm)-$20.4M
Income available to common (ttm)-$28.6M
Profitability
Profit Margin (ttm)-81.1%
Operating Margin (ttm)-74.0%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter31-Dec-2000
Management Effectiveness
Return on Assets (ttm)-13.38%
Return on Equity (ttm)-27.19%
Financial Strength
Current Ratio (mrq)2.50 
Debt/Equity (mrq)1.05 
Total Cash (mrq)$62.4M
Short Interest
As of 8-Aug-2001
Shares Short30.0K
Percent of Float0.1%
Shares Short
(Prior Month)
31.0K
Short Ratio1.58 
Daily Volume19.0K
ADR Information
Shares/ADR10
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Dec-2000);   dollar amounts based on an exchange rate of 1.45 Dollars/British Pounds

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.